Founder and CEO
Dr. Scott Whitcup is the Founder and CEO of Akrivista, a company focused on developing novel treatments in ophthalmology. Previously, he was EVP, R&D and Chief Scientific Officer at Allergan with experience running a large R&D organization with > 2500 employees and an annual budget of >$1B, and participated in many commercial launches. He has R&D expertise in ophthalmology, CNS, urology, dermatology, medical aesthetics, anti-infectives, and obesity. He has been extensively involved in business development, and has Board experience on both private and public companies.